[AKRO] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
16-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -0.37%
YoY- 74.60%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -21,403 -16,207 -11,886 -15,611 -15,554 -7,228 -5,362 150.99%
Tax -6 -1,323 -1,237 -46 -16,309 -7,609 -5,362 -98.90%
NP -21,403 -16,207 -11,886 -15,611 -15,554 -7,228 -5,362 150.99%
Tax Rate - - - - - - - -
Total Cost 21,403 16,207 11,886 15,611 15,554 7,228 5,362 150.99%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.63 -0.57 -0.42 -0.55 -0.56 -2.21 -0.20 114.43%
EPS Diluted -0.63 -0.57 -0.42 -0.55 -0.56 -2.21 -0.20 114.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.